Biogen  logo
Biogen BIIB
€ 165.49 0.32%

Geschäftsbericht 2025
hinzugefügt 06.02.2026

report update icon

Biogen Langfristiger Schuldenstrom 2011-2026 | BIIB

Langfristiger Schuldenstrom Jährlich Biogen

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
80.4 M 86.4 M 90.3 M 97.2 M 89.1 M - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
97.2 M 80.4 M 88.7 M

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Amarin Corporation plc Amarin Corporation plc
AMRN
1.87 M $ 14.88 0.1 % $ 6.07 B irlandaIrlanda
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Adagene Adagene
ADAG
1.18 M $ 3.16 10.7 % $ 178 M chinaChina
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 0.79 -7.27 % $ 4.31 M chinaChina
AlloVir AlloVir
ALVR
10.8 M - 4.14 % $ 49.1 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
202 M $ 60.79 1.55 % $ 124 B usaUSA
BioNTech SE BioNTech SE
BNTX
39.5 M $ 106.17 0.39 % $ 27.2 B germanyGermany
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.49 -0.55 % $ 8.4 B australiaAustralia
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Aptose Biosciences Aptose Biosciences
APTO
428 K - -45.71 % $ 1.2 M canadaCanada
Athira Pharma Athira Pharma
ATHA
414 K - - $ 269 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
14.2 M $ 215.79 -1.06 % $ 5 B danmarkDanmark
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
538 K - 17.91 % $ 11.1 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
829 K $ 39.8 3.81 % $ 4.11 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
Brickell Biotech Brickell Biotech
BBI
49 K - -5.38 % $ 6.06 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
Athersys Athersys
ATHX
1.01 M - 3.77 % $ 22.4 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
18.6 M $ 52.89 8.09 % $ 4.76 B schweizSchweiz
BeiGene, Ltd. BeiGene, Ltd.
BGNE
17.6 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
5.05 M $ 1.42 2.54 % $ 362 M britainBritain
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
224 M $ 14.82 1.26 % $ 4.58 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
410 K - 1.93 % $ 17.4 M usaUSA
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany